See also this year's filing and all EDGAR filings for this company.
PDF Report 0001840233_2022_Xilio_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001840233, Xilio Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 202,517,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 15,543,000 |
| 4 | LiabilitiesCurrent | 12,778,000 |
| 5 | LiabilitiesNoncurrent | 10,225,000 |
| 6 | remainder_Liabilities | 9,628,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 23,856,000 |
| 9 | ResearchAndDevelopmentExpense | 51,188,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -756,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 218,060,000 |
| 1 | Liabilities | 32,631,000 |
| 2 | Expenses | 75,044,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 185,429,000 |
| 5 | NetIncome | -75,800,000 |
| 6 | ComprehensiveNetIncome | -75,800,000 |
| 7 | BaseVar | 163,245,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.62 |
| 9 | EconomicCapitalRatio | 3.43 |
Edgar->Model Mapping
Feature Distribution
